IASLC > International Association for the Study of Lung Cancer > Conferences & Events > Event Details
How to Interpret the Outcomes of Comparative Effectiveness Studies in Early-Stage NSCLC: A Primer for Radiation Oncologists
June 25, 2019 | Online


In the absence of completed randomized clinical trials of surgeryversus stereotactic ablative radiotherapy, other comparative effectivenessstudies comparing both treatments in stage I non-small cell lung cancer havebeen published. These studies have occasionally reached different andconflicting conclusions. Nevertheless, population studies show a shift intreatment patterns for this patient group.

What you should expect to learn

The objective of this webinar is to provide clinicians with anappreciation of the limitations of population and institutional data forcomparative effectiveness studies of surgery versus stereotactic ablativeradiotherapy. This one hour webinar will feature two presentations and aquestion/answer session.

Moderator:  Professor S. Senan  MRCP, FRCR, PhD
Department of Radiation Oncology, 
Cancer Center Amsterdam
VU University Medical Center

Chad Rustoven, MD
Assistant Professor
University of Colorado School of Medicine
Department of Radiation Oncology

Pamela Samson, MD, MPHS
Department of Radiation Oncology, Resident
Washington University in St. Louis

Outcomes Data from Population Studies - Chad Rustoven, MD

Can we use retrospective institutional outcomes to inform prospective treatment allocation and shared decision making - Pamela Samson, MD

Following the presentations Suresh Senan MD, PhD, FRCR will moderate the question/answer session and lead the discussion.


Member Experience Department